Asymmetric collimation can significantly reduce patient radiation dose during pulmonary vein isolation
Stijn De Buck, Andre La Gerche, Joris Ector, Jean-Yves Wielandts, Pieter Koopman, Christophe Garweg, Dieter Nuyens, Hein Heidbuchel
Europace | OXFORD UNIV PRESS | Published : 2012
The authors wish to make known the following disclosures. H. H. is a member of the scientific advisory board of Siemens Medical Solutions, Bayer, Daicchi-Sankyo, Merck, Sanofi-Aventis, Boehringer-Ingelheim and Bristol-Myers Squib, and receives unconditional research grants through the University of Leuven from St Jude Medical, Medtronic, Biotronik, and Boston Scientific Inc. S. D. B. and H. H. receive research funding through the University of Leuven from Siemens Medical Solutions for related topics. This research was academically driven and not supported by specific grants.